MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
In May 2008, the World Health Assembly agreed on a Global Strategy and Plan of Action aimed at reforming the medical R&D system and enhancing access to medicines for patients in developing countries.
Too often MSF staff find themselves in the painful situation where they don't have adequate medical tools to treat their patients. This is largely because the global system of pharmaceutical Research and Development doesn't developm medicines for diseases that mostly affect poor people.
In May 2008, the World Health Assembly voted through a resolution calling for concrete ways to stimulate innovation into diseases that mainly affect those in developing countries. In this report, produced by Laura McCullagh, patients and MSF doctors explain why urgent change is needed Click here to listen to the audio feature
Cough Up for TB! The Underfunding of TB Research Across Europe (October 2009) 
Presenation: Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun
